Function is a precision medicine company that focuses on understanding cancer at a deeper, more individualized level. By utilizing a CRISPR-enabled platform, Function moves beyond conventional gene sequencing methods to assess gene function directly. This innovative approach allows the company to uncover unique insights into each patient's cancer, identifying therapeutic opportunities that are tailored to their specific genetic makeup. This patient-centric methodology aims to enhance the effectiveness of current treatments and pave the way for the development of next-generation cancer therapies.

The company's commitment to precision medicine is reflected in its pipeline of products, which are designed to address the complexities of cancer as a genetic disease. By integrating advanced genomic technologies with functional analysis, Function seeks to provide a more comprehensive understanding of cancer biology. This strategy not only aims to improve treatment outcomes for patients but also positions Function at the forefront of cancer research and therapy development, ultimately striving to transform the way cancer is treated.

United States

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to understand cancer in unprecedented and patient-specific detail. By moving beyond traditional gene sequencing to measuring gene function, Function Oncology aims to identify optimal therapeutic opportunities for patients and advance the next generation of targeted cancer therapies.

Function

Company Details